Portal de Periódicos da CAPES

Endovascular Treatment of Ruptured Vertebral Artery Dissection in the Acute Stage

2003; Karger Publishers; Volume: 16; Issue: 3 Linguagem: Inglês

10.1159/000071135

1421-9786

Joji Inamasu, Yoshiki Nakamura, Ryoichi Saito, Y. Kuroshima, Keita Mayanagi, Kiyoshi Ichikizaki, Satoshi Onozuka, Sadao Suga, Takeshi Kawase,

Moyamoya disease diagnosis and treatment

Research Articles| July 18 2003 Endovascular Treatment of Ruptured Vertebral Artery Dissection in the Acute Stage Subject Area: Cardiovascular System , Neurology and Neuroscience Joji Inamasu; Joji Inamasu aDepartment of Neurosurgery, National Tokyo Medical Center and Search for other works by this author on: This Site PubMed Google Scholar Yoshiki Nakamura; Yoshiki Nakamura aDepartment of Neurosurgery, National Tokyo Medical Center and Search for other works by this author on: This Site PubMed Google Scholar Ryoichi Saito; Ryoichi Saito aDepartment of Neurosurgery, National Tokyo Medical Center and Search for other works by this author on: This Site PubMed Google Scholar Yoshiaki Kuroshima; Yoshiaki Kuroshima aDepartment of Neurosurgery, National Tokyo Medical Center and Search for other works by this author on: This Site PubMed Google Scholar Keita Mayanagi; Keita Mayanagi aDepartment of Neurosurgery, National Tokyo Medical Center and Search for other works by this author on: This Site PubMed Google Scholar Kiyoshi Ichikizaki; Kiyoshi Ichikizaki aDepartment of Neurosurgery, National Tokyo Medical Center and Search for other works by this author on: This Site PubMed Google Scholar Satoshi Onozuka; Satoshi Onozuka bDepartment of Neurosurgery, Keio University School of Medicine, Tokyo, Japan Search for other works by this author on: This Site PubMed Google Scholar Sadao Suga; Sadao Suga bDepartment of Neurosurgery, Keio University School of Medicine, Tokyo, Japan Search for other works by this author on: This Site PubMed Google Scholar Takeshi Kawase Takeshi Kawase bDepartment of Neurosurgery, Keio University School of Medicine, Tokyo, Japan Search for other works by this author on: This Site PubMed Google Scholar Cerebrovasc Dis (2003) 16 (3): 306–308. https://doi.org/10.1159/000071135 Article history Received: April 12 2002 Accepted: October 14 2002 Published Online: July 18 2003 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Joji Inamasu, Yoshiki Nakamura, Ryoichi Saito, Yoshiaki Kuroshima, Keita Mayanagi, Kiyoshi Ichikizaki, Satoshi Onozuka, Sadao Suga, Takeshi Kawase; Endovascular Treatment of Ruptured Vertebral Artery Dissection in the Acute Stage. Cerebrovasc Dis 1 July 2003; 16 (3): 306–308. https://doi.org/10.1159/000071135 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsCerebrovascular Diseases Search Advanced Search Article PDF first page preview Close Modal 2003Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.